Health House International Limited (ASX:HHI)

Company Overview

Health House International Limited is an Australia-based international distributor of medicinal cannabis. Its primary activities include operations in the pharmaceutical wholesale and distribution sectors. It has two operating subsidiaries: Health House Pharma Limited, an international pharmaceutical distribution business in the United Kingdom and Health House International Pty Limited, a medicinal cannabis distribution business in Australia. Th products distributed by the Company include iX Biopharma’s Xativa, which is formulated using WaferiX, which is patented sublingual delivery technology, and Zelira Therapeutics’ cannabinoid-based customized medicines, including HOPE1, HOPE2 and Zenivol oil blended with pharmaceutical-grade sunflower oil. It distributes Levin Health’s cannabinoid-based, chronic pain medicines, such as LEVIN CBD 100 and LEVIN Balance 10:12. It also distributes products of various companies, such as Satipharm, HAPA pharm, Ananda Hemp and Little Green Pharma.